NSE ScannerComparison · NSE · data 2026-11-01
Aarti Pharmalabs Limited vs Symbiotec Pharmalab Limited
In plain words
Size: Symbiotec Pharmalab Limited is about 1 times the market value of Aarti Pharmalabs Limited.
Differences in the numbers, not a recommendation of either stock.
Side by side
| AARTIPHARM | SYMBIOTEC | |
|---|---|---|
| Price | ₹872.7 | ₹1,246.3 |
| Market cap | ₹7,922 cr | ₹8,001 cr |
| P/E | 30.9 | — |
| P/B | 3.5 | — |
| ROE | 8.5% | — |
| ROCE | 11.5% | — |
| Debt / equity | 0.36 | — |
| Operating margin | 17.7% | — |
| Dividend yield | 0.40% | 0.00% |
| Sales growth, 3 years (yearly) | -2.6% | — |
| Profit growth, 3 years (yearly) | -3.3% | — |
| 1-year return | 4.9% | 26.1% |
| Revenue, last 12 months | ₹2,161 cr | — |
| Net profit, last 12 months | ₹257 cr | — |
| Latest quarter | Dec 2025 | Jun 2026 |
| Quarter net profit | ₹46 cr | ₹14 cr |
| Quarter profit vs a year earlier | -37.3% | — |
| Promoter holding | 42.86% | 33.28% |
| Health check | Average (6/10) | Strong (8.5/10) |